Prospective monitoring reveals dynamic levels of T cell immunity to mycobacterium tuberculosis in HIV infected individuals

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Mitchell, Jessica E ^a,b   Chetty, Shivan ^b   Govender, Pamla ^b   Pillay, Mona ^b   Jaggernath, Manjeetha ^b   Kasmar, Anne ^c   Ndung'u, Thumbi ^a,b   Klenerman, Paul ^d   Walker, Bruce D ^a,b   Kasprowicz, Victoria O ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOKINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TUBERCULOSIS; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CHEMOKINE CXCL10; CHEMOKINE CXCL9; COINFECTION; ENZYME-LINKED IMMUNOSPOT ASSAY; HIV; HIV INFECTIONS; HUMANS; LIMIT OF DETECTION; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TIME FACTORS; TUBERCULOSIS; VIRAL LOAD;

EID: 84862006513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037920     Document Type: Article

References (50)

1. Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlosser S, (2011) Within-Subject Variability of Mycobacterium tuberculosis-Specific Gamma Interferon Responses in German Health Care Workers. Clin Vaccine Immunol 18: 1176 1182.
2. WHO (2010 guidelines under development) Policy statement on preventive therapy against TB in people living with HIV.
3. Shafer RW, Edlin BR, (1996) Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 22: 683 704.
4. Hanifa Y, Grant AD, Lewis J, Corbett EL, Fielding K, (2009) Prevalence of latent tuberculosis infection among gold miners in South Africa. Int J Tuberc Lung Dis 13: 39 46.
5. Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, (2009) Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 9: 15.
6. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, (2002) Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16: 2285 2293.
7. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, (2004) Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364: 2196 2203.
8. Clark SA, Martin SL, Pozniak A, Steel A, Ward B, (2007) Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 150: 238 244.
9. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, (2007) Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 175: 514 520.
10. Raby E, Moyo M, Devendra A, Banda J, De Haas P, (2008) The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 3: e2489.
11. Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly KD, (2008) Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One 3: e1441.
12. Pai M, O'Brien R, (2007) Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 4: e208.
13. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, (2011) Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax.
14. Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN, (2006) Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 193: 354 359.
15. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174: 831 839.
16. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 4: e192.
17. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, (2006) Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 174: 349 355.
18. Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, (2007) Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 175: 618 627.
19. Kipfer B, Reichmuth M, Buchler M, Meisels C, Bodmer T, (2008) Tuberculosis in a Swiss army training camp: contact investigation using an Interferon gamma release assay. Swiss Med Wkly 138: 267 272.
20. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357: 2017 2021.
21. Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P, (2005) Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 9: 1242 1247.
22. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, (2004) Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38: 754 756.
23. Lalvani A, (2004) Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 38: 757 759.
24. Leyten EM, Mulder B, Prins C, Weldingh K, Andersen P, (2006) Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposure. J Clin Microbiol 44: 1197 1201.
25. Hill PC, Fox A, Jeffries DJ, Jackson-Sillah D, Lugos MD, (2005) Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 40: 273 278.
26. Richeldi L, Ewer K, Losi M, Bergamini BM, Millington K, (2007) T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 119: e1 5.
27. van Brummelen SE, Bauwens AM, Schlosser NJ, Arend SM, (2010) Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test. Clin Vaccine Immunol 17: 937 943.
28. Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, (2001) Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183: 469 477.
29. Menzies D, Pai M, Comstock G, (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340 354.
30. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, (2010) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection- United States, 2010. MMWR Recomm Rep 59: 1 25.
31. Kasprowicz VO, Mitchell JE, Chetty S, Govender P, Huang KH, (2011) A molecular assay for sensitive detection of pathogen-specific T-cells. PLoS One 6: e20606.
32. Kasprowicz V, Isa A, Tolfvenstam T, Jeffery K, Bowness P, (2006) Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19. J Virol 80: 11209 11217.
33. Keating SM, Bejon P, Berthoud T, Vuola JM, Todryk S, (2005) Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria. J Immunol 175: 5675 5680.
34. Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, (2006) Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 6: 66.
35. Connell TG, Davies MA, Johannisen C, Wood K, Pienaar S, (2010) Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infect Dis 10: 138.
36. Houlihan CF, Mutevedzi PC, Lessells RJ, Cooke GS, Tanser FC, (2010) The tuberculosis challenge in a rural South African HIV programme. BMC Infect Dis 10: 23.
37. Barnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, (2008) High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS 22: 139 144.
38. DOH (2009) Health Systems Research and Epidemiology: Notification System. Trust HS, eds. editor.
39. Smith SG, Joosten SA, Verscheure V, Pathan AA, McShane H, (2009) Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 4: e7972.
40. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M, (2009) Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 4: e8517.
41. Tuuminen T, Tavast E, Vaisanen R, Himberg JJ, Seppala I, (2010) Assessment of Imprecision in gamma interferon release assays for the detection of exposure to Mycobacterium tuberculosis. Clin Vaccine Immunol 17: 596 601.
42. Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, (2008) T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 3: e1850.
43. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R, (2007) T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 7: 428 438.
44. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, (2007) Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 14: 880 885.
45. Cehovin A, Cliff JM, Hill PC, Brookes RH, Dockrell HM, (2007) Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol 14: 796 798.
46. Bassett IV, Wang B, Chetty S, Giddy J, Losina E, (2010) Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51: 823 829.
47. Diel R, Loddenkemper R, Nienhaus A, (2010) Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 137: 952 968.
48. Denkinger CM, Dheda K, Pai M, (2011) Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 17: 806 814.
49. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 341: 1174 1179.
50. Geng E, Kreiswirth B, Driver C, Li J, Burzynski J, (2002) Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 346: 1453 1458.